Alston & Bird is noted for representing Larkspur Health Acquisition Corp. in a planned $109 million merger with ZyVersa Therapeutics Inc.
In the News
July 21, 2022
Law360 | 3 Firms Guide Biopharma Co. ZyVersa’s $109M SPAC Merger
Media Contact